Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,133
Closed -$1.42M 1297
2017
Q3
$1.42M Buy
12,133
+7,715
+175% +$976K 0.03% 777
2017
Q2
$556K Buy
+4,418
New +$562K 0.01% 923
2016
Q1
Sell
-6,057
Closed -$657K 790
2015
Q4
$657K Buy
6,057
+3,865
+176% +$431K 0.05% 417
2015
Q3
$242K Sell
2,192
-14,350
-87% -$1.61M 0.04% 622
2015
Q2
$1.72M Sell
16,542
-4,176
-20% -$432K 0.07% 470
2015
Q1
$1.9M Buy
20,718
+15,890
+329% +$1.31M 0.08% 502
2014
Q4
$353K Buy
+4,828
New +$315K 0.02% 678

Other funds holding INCY

AHL Partners's INCY Position: Q4 2017 in Review

AHL Partners sold out of Incyte (INCY) in Q4 2017, closing a stake of 12,133 shares — an estimated $1.42M sold.

AHL Partners first reported a position in INCY in Q4 2014 and held it in 7 quarters. The position peaked at $1.9M in Q1 2015. 503 funds tracked by Wall St. Rank hold INCY as of Q4 2017.

  • AHL Partners reported no remaining Incyte position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 12,133 Incyte shares in Q4 2017, an estimated $1.42M.
  • AHL Partners first reported a position in Incyte in Q4 2014 and held it in 7 quarters.
  • AHL Partners's Incyte position peaked at $1.9M in Q1 2015.
  • 503 funds tracked by Wall St. Rank held Incyte as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.